✦ LIBER ✦

Efficacy and safety of gefitinib in chemonaive patients with advanced non-small cell lung cancer treated in an Expanded Access Program

✍ Scribed by Govindan, Ramaswamy; Natale, Ronald; Wade, James; Herbst, Roy; Krebs, Annetta; Reiling, Richard; Hensing, Thomas; Wozniak, Antoinette; Belani, Chandra P.; Kelly, Karen; Ochs, Judith

Book ID: 119319405
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 141 KB
Volume: 53
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2006.04.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antitumor Activity and Tolerability of G

Antitumor Activity and Tolerability of Gefitinib in Patients with Non–Small-Cell Lung Cancer Treated in an Expanded Access Program

✍ Neelam T. Shah; Vincent A. Miller 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 781 KB

Outcomes of patients with advanced non-s

Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study

✍ Jänne, Pasi A.; Gurubhagavatula, Sarada; Yeap, Beow Y.; Lucca, Joan; Ostler, Pat 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Asian Ethnicity as a Predictor of Respon

Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program

✍ Sheeba K. Thomas; Frank V. Fossella; Diane Liu; Rainell Schaerer; Anne S. Tsao; 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 898 KB

825 Statistical analysis of survival in

825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results

✍ M. Wolf; D. Farina-Sisofo; J. Grous; G. Kennealey; J. Ochs 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Improvements of quality of life in patie

Improvements of quality of life in patients with advanced non-small cell lung cancer treated with gefitinib

✍ Yanmei Zou; Hua Xiong; Shiying Yu 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 76 KB

Efficacy and tolerability of gefitinib i

Efficacy and tolerability of gefitinib in pretreated elderly patients with advanced non-small-cell lung cancer (NSCLC)

✍ Cappuzzo, F; Bartolini, S; Ceresoli, G L; Tamberi, S; Spreafico, A; Lombardo, L; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 85 KB